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Abstract
As the leading cause of death and disability in individuals under the age of 45-years-old,
Traumatic Brain Injury (TBI) is a public health crisis that demands the attention of the
scientific and medical community [28]. The majority of all TBIs that occur in the United
States each year are a non-deadly yet detrimental form of closed brain injury known as
mild TBI (mTBI) or concussion [6]. Athletes, young people and military personnel all face
a high risk of acquiring mTBI as a result of their environments. In our study we have
chosen to model repeated mTBI (rmTBI) in the mouse in order to gain a boarder
understanding of the mechanisms of injury and cellular changes occurring immediately
after and months following rmTBI. Over a 3-month time course, we observed a gradual,
yet significant, increase in lateral ventricular volume in mice that had induced rmTBI over
that of control mice. In addition we observed changes in microglial morphology and
activation throughout the brain immediately after rmTBI and up through 3-months
following injury. Both of our findings contribute to the hypothesis that sustaining repeated
rmTBIs over time can lead to an increased risk for neurodegeneration or poor recovery.
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Introduction
Traumatic brain injury (TBI), an acquired injury resulting from a rapid and sudden
blow to the head, is a serious health concern. The CDC estimates that on average 1.7
million people sustain a TBI each year, costing the United States approximately 76.5
billion dollars in direct and indirect medical costs annually [6]. Traumatic brain injury can
potentially leave fully functioning individuals handicapped or impaired with little hope for
recovery, putting strain on family and caregivers. Young adults, athletes, and military
personnel make up a large group of people routinely diagnosed with a non-deadly yet
symptomatically significant form of TBI known as mild TBI (mTBI) [3] [6].
Improvements have been made in identifying patients with concussions or mTBI, however
treatment options are limited, and little is known about the long-term effects of physical
injury to the brain or the brains capacity for recovery [17]. Physical symptoms of mTBI
including headache, dizziness, or memory loss often disappear within a few weeks of the
injury [5]. Sustaining repeated mTBI (rmTBI), however, may lead to Chronic Traumatic
Encephalopathy (CTE), a severe neurodegenerative disease characterized by diffuse
accumulations of hyperphosphorylated tau throughout the brain. Patients diagnosed
posthumously with CTE have been as young as 17-years-old [3] [21] [26]; however, the
usual age of onset is between 40 and 50 years old.
Serious	
   cognitive	
   decline,	
   short-‐term	
   memory	
   loss,	
   personality	
   changes,	
  
aggression,	
   and	
   suicidal	
   thoughts	
   are	
   all	
   symptoms	
   associated	
   with	
   CTE.	
   Advanced	
  
forms	
   of	
   CTE	
   may	
   be	
   misdiagnosed	
   as	
   other	
   neurodegenerative	
   diseases	
   such	
   as	
  
Alzheimer’s	
   disease	
   or	
   even	
   Parkinson’s	
   disease,	
   as	
   the	
   clinical	
   presentations	
   are	
  
similar	
   [21].	
   CTE	
   patients	
   however,	
   rarely	
   present	
   with	
   amyloid-‐β	
   plaques,	
   and	
   the	
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tau	
   pathology	
   found	
   in	
   CTE	
   is	
   distinct	
   from	
   that	
   seen	
   in	
   Alzheimer’s	
   disease.	
  
Neurofibullary	
   Tau	
   tangles	
   are	
   usually	
   distributed	
   in	
   the	
   frontal	
   and	
   temporal	
  
cortices	
   in	
   close	
   contact	
   with	
   cerebral	
   vesicles	
   or	
   in	
   the	
   cerebral	
   sulci.	
   A	
   CTE	
   brain	
  
shows	
   pronounced	
   atrophy	
   in	
   the	
   cerebral	
   cortex,	
   medial	
   temporal	
   lobe	
   and	
  
diencephalon,	
  and	
  distinctly	
  enlarged	
  lateral	
  ventricles	
  [13] [21].	
  	
  
The	
   association	
   of	
   ventriculomegaly	
   with	
   CTE	
   was	
   what	
   initially	
   drew	
   the	
  
Conover	
   lab	
   to	
   study	
   mTBI	
   in	
   a	
   mouse	
   model.	
   The	
   Conover	
   lab	
   focuses	
   research	
   on	
  
neurogenesis	
   of	
   the	
   mammalian	
   Subventricular	
   Zone	
   (SVZ),	
   a	
   region	
   that	
   lies	
   along	
  
the	
  lateral	
  walls	
  of	
  the	
  lateral	
  ventricles	
  [20].	
  The	
  SVZ	
  is	
  one	
  of	
  two	
  neural	
  stem	
  cell	
  
niches	
  that	
  persists	
  into	
  adulthood,	
  however	
  in	
  response	
  to	
  stressors	
  such	
  as	
  aging,	
  
the	
  SVZ	
  tends	
  to	
  show	
  deterioration	
  [28].	
  The	
  SVZ	
  is	
  a	
  highly	
  organized	
  network	
  made	
  
up	
   of	
   four	
   distinct	
   cell	
   types:	
   ependymal	
   cells,	
   SVZ	
   astrocytes,	
   transitory	
   amplifying	
  
cells,	
  progenitor cells, and neuroblasts [20] and [25]. In the adult SVZ, proliferating radial
glia cells (astrocytes) generate transient amplifying cells, which in turn give rise to
neuroblasts. In the rostral migratory stream (RMS), a chain of neuroblasts from the SVZ
migrates though tubes of astrocytes towards the olfactory bulb. Once the neuroblasts have
reached the core of the olfactory bulb the immature neurons disengage from the RMS to
differentiate into cells required for olfactory function [22]. Ependymal cells are simple
ciliated epithelial cells that line the interior walls of the lateral ventricles. Junctions connect
the ependymal cells together at the apical end of the cell, creating an interface between the
interior of the ventricles and the rest of the brain [5]. The structure and enzymatic output
of ependymal cells creates a barrier between the cerebrospinal fluid (CSF) and the brain
parenchyma and assists in cerebral fluid balance, toxin metabolism and secretion. The
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ependymal lining may also serve to protect the SVZ stem cell niche. Damaged ependymal
cells are typically replaced by astrocytes, which form a glial scar. The glial scar has a
similar morphology to the ependymal cell, however it does not contain the same cilia or
protein channels that may assist in creating the CSF-brain barrier [5].
Stem cells and neuroblasts residing in the SVZ may be a potential source of new
cells for neural tissue repair after mTBI. Following experimentally induced ischemic
stroke in rats, several studies have shown neuroblasts from the SVZ migrate to the site of
injury [17]. The majority of migrating neuroblasts that reach injured stroke regions usually
remain undifferentiated, and those neuroblasts that do differentiate typically die, as they
are unable to integrate into mature neuronal networks. An increase in neurogenesis in the
SVZ has been shown in mouse models with induced TBI, however determining the fate of
differentiated cells and their migratory patterns remains a challenge [17]. Although there is
significant interest within the scientific community in neural repair, little is actually
understood about how a single mTBI or multiple rmTBI might alter or change the neural
stem cell niche.

The initial aim of our rmTBI study was to determine whether any

changes in ventricular volume could be observed over a 3-month period following rmTBI
in mice. The gross ventriculomegaly seen in human CTE patients led us to hypothesize that
rmTBI would result in an increase in the ventricular volume and an increase in glial
scarring along the ependymal lining [28]. Damage to the lateral wall may directly impact
the brain’s response to physical injury and capacity for regeneration.
Recent studies have shown that microglia, the brain’s resident immune cells, also
play a role in SVZ neurogenesis [17] [29]. Microglia are responsible for surveying the
brain for areas of damage, and are known to exhibit distinct changes in cellular
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morphology and physiology in response to neuronal injury or infection [2], [18] and [23].
A healthy brain contains as many microglia as it does neurons [2]. In the resting state,
microglia are identified as “ramified” with characteristically small cellular bodies and
numerous thin processes extending out from the soma [18]. While the fine processes of
ramified microglia are continuously moving in order to probe their environment, the soma
remains relatively still [18]. Ramified microglia are rarely seen touching one another;
however, they are often found in direct contact with astrocytes or neurons [2]. Microglia
become “activated” in response to minute alterations in brain chemistry, including
extracellular ATP, cytokines, necrotic tissue and neurotransmitters [18] [23]. Receptors on
the surface of microglial membranes bind to such molecules, and signal for the cell to
undergo a complex set of phenotypic changes, transforming into an “activated microglia.”
Activated microglia take on a macrophage-like morphology, migrate towards sites of
injury or infection, secrete numerous cytokines, phagocytose dead cells or debris and
proliferate [18] [23]. An activated microglia will upregulate the expression of Iba-1, a
cytoplasmic protein not expressed in any other neuronal cells, making it an ideal target for
immunohistochemical assays [8].
Microglia take on one of two distinct subtypes following activation, M1 or M2 [8].
The M1 cells are characterized as having a proinflammatory profile, producing high levels
of interferon-gamma (IFN-γ), tumor necrosis factor (TNF-α), interleukin-1β (IL-1β), IL12 [7] [11]. M2 microglia act in opposition to M1 cells by dampening inflammation
through the release of anti-inflammatory cytokines including IL-10 and transforming
growth factor (TGF)-β. M2 cells also contribute to brain recovery by phagocytosing
cellular debris [11].
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During early postnatal development microglia are found in semi-activated states
concentrated in the two neurogenic regions of the brain, the SVZ and the hippocampus [9].
The cytokines released by partially activated microglia have been shown to play a role in
proliferation within the SVZ niche [27]. The function of microglia in neurogenesis is still
not fully understood, however many studies illustrate a beneficial role for partially
activated microglia in neurogenic environments during development or after injury [29].
When mTBI occurs, lateral acceleration and deceleration of the brain within the
skull causes primary mechanical damage, resulting in the shearing of neurons, glia and
blood vessels along with stretching of epithelial tissue [19]. The physical damage to tissue
and breakdown of membranes leads to what is known as secondary injury, where
neurotransmitters,

ions

and

free

radicals

escape

from

dying

cells

inducing

neuroinflammation and apoptosis [19] [30]. Responding to the accumulation of
neurochemical molecules in the extracellular space, microglia become activated, taking on
the M1 subtype, releasing pro-inflammatory cytokines, nitric oxide and reactive oxygen
species into their environment [11]. The M1 proinflammatory cascade is important for the
initiation of the immune response within the brain; however, if left unbalanced by the M2
anti-inflammatory process individuals may experience lasting mTBI symptoms or poor
recovery. Repeatedly exposing the brain to mechanical injury as seen in athletes with
rmTBI, may prevent microglial subpopulations from transitioning into M2 subtypes,
leading to prolonged neuroinflammation and an increased risk for neurodegeneration [7].
The second aim of this study was to characterize morphological changes in
microglia in mice following rmTBI. Coronal sections of brain regions susceptible to mTBI
including the lateral ventricles, hippocampus, corpus callosum, and cortex were analyzed
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via immunohistochemistry immediately following rmTBI and 3 months after injury.
While other groups have shown mTBI can activate microglia, our study indicates that
repeated head trauma in mice results in a sustained proinflammatory profile up to three
months following injury. We hypothesize that these findings have broad implications for
rmTBI recovery and the progression of neurodegeneration following rmTBI.
Understanding the neuroinflammatory process and timeline may help researchers design
successful therapeutic drugs or implement better return to play policies to avoid further
injury [19].

Methods
Currently, neuroimaging techniques, such as MRI, are the best ways to study
rmTBI in living humans. While there have been significant advances in radiology over the
past decade, the imaging technology does not yet exist to view changes occurring within
cells. In addition the costs of operating advanced MRI machines and collecting large pools
of data is very expensive. This leaves post-mortem tissue analysis as the only method to
study human rmTBI related brain changes at the microscopic level. When researchers
examine post-mortem tissue of individuals known to have sustained multiple mTBIs
throughout life, neurodegeneration is often advanced. It may also be challenging to
distinguish age-related changes from those caused by rmTBI. A mouse model provides an
opportunity to study the effects of rmTBI at various intervals following injury. A large
body of literature indicates numerous animal models have already been developed to study
TBI [10] [14] [30]; however, few models exist that accurately replicate the kind of
repeated mild concussive injury an athlete may sustain on the playing field. The severity of
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any TBI is highly dependent on how and where the individual was hit on the head, as well
as their age, gender, and genetics [30]. The mouse model allows many of these variables to
be controlled for, allowing us to develop a more generalized and simplified understanding
of the primary and secondary injuries that occur following rmTBI. Models such as the
fluid percussion injury (FPI) require the researcher to perform a craniotomy over the
midline or parietal bone of the mouse, before a fluid pressure pulse is delivered directly to
the dura, displacing the brain to induce injury to the tissue [30]. While this method can
replicate the intracranial hemorrhage and neural swelling seen in human TBI, it is
unrealistic and does not mimic any injury a human patient might ever sustain. The
craniotomy also places the animal at an increased risk of infection, which could alter
studies of microglial activation.
In 2012, Kane et al. developed a unique mouse model to specifically study rmTBI.
Their model can accurately induce repeated mild concussive injuries over time and
includes features that allow for free movement of the animal’s head and torso during rapid
acceleration and deceleration. Even after multiple hits to the head, skull fractures and
intracranial bleeding are rarely observed in their mice [14]. We selected this effective and
uncomplicated model for our studies of rmTBI on the lateral ventricles, SVZ and
microglial activation.
The apparatus used by Kane et al to induce rmTBI is depicted in figure 1 [14]. Two
Plexiglas pieces (15cm length x 9 cm width x 23 cm depth) make up the frame of the
apparatus. An aluminum foil sheet is used to create a bridge across the top of the Plexiglas
frame. A sponge cushion (15 cm x 9 cm x 13 cm) is placed 10 cm below the aluminum foil
bridge. After being anesthetized with isoflurane, the mouse is placed on the aluminum foil
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bridge with its head directly under a PVC guide tube (20 mm diameter x 1.5 m length). A
95g solid brass weight is released 40 mm from the bottom of the PVC tube, and falls
directly onto the midline of the mouse’s head between the ears. When the weight makes
contact with the mouse the aluminum foil sheet tears apart, allowing the mouse to free fall
and perform a 1800 flip. The mouse will land supine on the cushion 10 cm below the initial
resting point. Sham control mice receive the same dose of isoflurane as experimental mice
and are positioned on the apparatus, but do not receive an impact or fall through the
aluminum foil bridge.

Figure	
   1.	
   rmTBI	
   apparatus	
   (A)	
   The	
  
entire	
  apparatus	
  including	
  the	
  (20	
  mm	
  
x	
   1.5	
   m)	
   PVC	
   delivery	
   tube	
   and	
  
plexiglas	
   frame.	
   (B)	
   Aluminum	
   foil	
  
bridge	
   is	
   pictured	
   over	
   the	
   Plexiglas	
  
frame.	
   (C)	
   The	
   mouse	
   is	
   shown	
   in	
   the	
  
initial	
   position	
   with	
   head	
   directly	
  
below	
   the	
   PCV	
   delivery	
   tube.	
   (D)	
  
Following	
  impact	
  with	
  95	
  g	
  weight	
  the	
  
mouse	
   breaks	
   through	
   the	
   aluminum	
  
foil	
   bridge,	
   completes	
   1800	
   flip	
   falling	
  
onto	
  the	
  cushion	
  10	
  cm	
  below	
  [14].	
  	
  

We designed two different rmTBI studies (Figure 2) that were carried out on the
Kane et al. group’s apparatus at Wayne State University [14]. In the first study C57 mice
received five hits with a 95 g weight over three days, with hits being carried out in the
morning and the evening. Following the fifth hit, mice received an injection of
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bromodeoxyuridine (BrdU) to mark cells undergoing DNA replication. Mice were then
sacrificed at four time points following the last impact: 2-hours, 2-weeks, 1-month and
three-months post injury. In our second study mice received an initial five hits over 3 days,
then underwent a resting period of two weeks. Following the resting period experimental
mice were subjected to an additional round of five hits over three days then a BrdU
injection immediately after the last impact. Mice from the second study were sacrificed at
three time points after the final injury: 2-hours, 1-month and 3-months following injury.

A	
  

B	
  

Figure	
   2.	
   	
   rmTBI	
   study	
   outline	
   (A)	
   Depicts	
   the	
   outline	
   for	
   the	
   initial	
   rmTBI	
   used	
   to	
  
complete	
   ventricular	
   volume	
   assessments.	
   (B)	
   Shows	
   the	
   second	
   rmTBI	
   study	
   outline	
  
employed	
  in	
  the	
  microglial	
  activation	
  studies.	
  	
  
Researchers from Wayne State University were responsible for inducing rmTBI
and sacrificing mice according to the established time line (Figure 2). Mice were scarified
via cardiac perfusion with saline and 4% PFA followed by excision of the entire brain.
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Brains were shipped in PBS to University of Connecticut where members of the Conover
Lab carried out all further analysis.
Immunohistochemistry
Control and experimental brains were processed and analyzed using the same
methodology. For both the ventricular volume analysis and microglial activation study,
brains were embedded in agarose, mounted on a virbratome (VT-1000S; Leica), and then
sectioned into 50 μm coronal slices. Sections were blocked in 10% Horse Serum
(Invitrogen) in PBS/0.1%Triton X-100 for one hour. For the ventricular volume studies,
brains were then incubated with rat anti-BrdU, mouse anti-GFAP (Abcam) and goat antiAquaporin-4 primary antibodies. The BrdU antibody marks cells that underwent division
at the time of the IP BrdU injection. GFAP (Glial Fibrillary Acidic Protein) is a marker for
reactive astrocytes, and Aquaporin-4 (AQP4) marks water channels located on the basallateral membrane of ependymal cells. Before applying the BrdU primary antibody the
sections were acid-fast treated.
For the microglial activation study rat anti-GFAP (Abcam), rabbit anti-Iba-1
(Wako) and mouse anti-Doublecortin (Abcam) were used as primary antibodies. Iba-1 is
an intracellular calcium binding protein that is highly expressed in activated microglia, and
doublecortin (DCX) is a marker for neuroblasts.
After 24 hours incubation with primary antibodies at 4oC, sections were rinsed
three times in PBS before the addition of corresponding Alexa Fluor dye-conjugated
secondary antibodies (Invitrogen) to the tissue for 1 hour at room temperature. Following
secondary antibody removal the tissue was rinsed two times, DAPI nuclear stain was
added to the tissue, then all sections were rinsed 3 additional times in PBS. Sections were
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mounted onto glass slides then coverslipped with Aqua-Poly/Mount (Polysciences) and
allowed to dry completely.
Ventricular Volume
To determine the volume of the lateral ventricles in control and rmTBI mice, the
lateral ventricles were viewed on a Carl Zeiss Axio Imager M2 Microscope with Apotome
(Carl Zeiss) at 10x then traced using StereoInvestigator software. Approximately 38 50μM
sections were traced to make up the entire lateral ventricle. Following tracing the sections
were uploaded and stacked in the program Neurolucida Explorer, to create a 3-D model of
the lateral ventricles.

Once the 3-D model was complete, the software was able to

calculate consistently accurate ventricular volumes. Figure 3 depicts stacked lateral
ventricle sections and a 3-D reconstruction of the brain and lateral ventricles. A students ttest p<.05, was performed on volume data and SEM error bars were added.

Figure	
  3.	
  	
  Lateral	
  Ventricle	
  Tracing	
  and	
  3D	
  Reconstruction	
  Stacked	
  lateral	
  ventricles	
  from	
  a	
  
(A)	
   control	
   mouse	
   and	
   (B)	
   rmTBI	
   mouse	
   in	
   the	
   Neurolucida	
   Explorer	
   program.	
   (C)	
   3-‐D	
  
reconstruction	
   of	
   stacked	
   coronal	
   showing	
   the	
   lateral	
   ventricles	
   and	
   whole	
   brain.	
   Lateral	
  
ventricle	
  volumes	
  were	
  calculated	
  from	
  3-‐D	
  reconstruction.	
  	
  	
  
	
  
Imaging of Microglia
Following immunohistochemical preparation, Iba-1+ microglia were imaged at 10x
on the Carl Zeiss Axio Imager M2 Microscope with Apotome (Carl Zeiss) using
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Hamamatsu ORCA-R2 digital camera C10600 and at 40x on a Leica TCS SP2 confocal
laserscan microscope. The gain and light exposure were kept constant throughout all
imaging.
Results
Expansion in the lateral ventricles following rmTBI
Reconstruction of the lateral ventricles from mice in the initial rmTBI study
revealed a gradual increase in lateral ventricular volume during a 3-month interval in
rmTBI mice over control mice. We noticed the greatest volume expansion in 3-month mice
and a slight decrease in volume from the 2-week to 1-month time points.

Microglial Activation Following rmTBI
Figure	
   4.	
   Lateral	
   ventricular	
   volume	
   expands	
   after	
   rmTBI.	
   Immediately	
   following	
  
the	
  5	
  hits	
  over	
  3	
  days	
  rmTBI	
  model,	
  mice	
  experience	
  ventricular	
  expansion.	
  The	
  lateral	
  
ventricles	
   continued	
   to	
   expand	
   over	
   the	
   course	
   of	
   the	
   3-‐month	
   interval	
   to	
   the	
   highest	
  
volume	
   recorded.	
   All	
   four	
   experimental	
   groups	
   show	
   significance	
   over	
   control	
   (*p<0.05,	
  
students	
  t-‐test,	
  SEM	
  error	
  Bars).	
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Four brain regions were selected to examine the effect of rmTBI on microglial activation.
The lateral ventricles were selected due their close association with the neurogenic SVZ
niche. The hippocampus was examined next as it is the other site of neurogenesis in the
brain. The corpus callosum was chosen for analysis, as it is made up of long white matter
tracts, which are highly susceptible to tearing as a result of the lateral
acceleration/deceleration and torsional brain movement occurring during rmTBI. Microglia
in the cortex by the site of impact were also analyzed for changes in morphology.
Changes in microglia morphology and activation varied in different brain regions
and was altered over time. Along the border of the lateral ventricles (Figure 5), an increase
in soma size can be observed in mice sacrificed 2-hours following rmTBI. Both increases
in soma size and cell process thickness are noticeable in rmTBI mice 3-months after injury.
In the hippocampus the rmTBI mice sacrificed 3-months after injury had more microglia
with larger cell bodies and thicker processes than 2-hour rmTBI mice or either control
mouse.

In the corpus callosum microglia appear more frequently in the activated

phenotype 2-hours after rmTBI than any other group. Within the cortex of rmTBI mice
sacrificed 2-hours following injury, microglia can be seen clustering together in direct
contact with one another. While this is highly uncommon among ramified resting
microglia, it has been observed in activated microglia. At 3-months post injury the
microglia in the cortex have much larger cellular bodies than age matched controls.
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Figure	
   5.	
   Lateral	
   Ventricle	
   microglial	
   expression.	
   Activated	
   microglia	
   express	
   Iba1.	
   rmTBI	
  
microglia	
  show	
  larger	
  cell	
  bodies	
  and	
  thicker	
  cell	
  processes	
  in	
  rmTBI	
  (B)	
  2-‐hours	
  post	
  injury	
  and	
  
(D)	
  3-‐month	
  post	
  injury	
  mice.	
  Control	
  mice	
  (A	
  and	
  C)	
  appear	
  similar	
  to	
  one	
  another.	
  	
  

Figure	
  6.	
  Activated	
  microglia	
  in	
  the	
  dentate	
  gyrus	
  of	
  the	
  hippocampus.	
  An	
  increase	
  in	
  the	
  number	
  
of	
   microglia	
   can	
   be	
   seen	
   in	
   the	
   (B)	
   2-‐hour	
   rmTBI	
   over	
   the	
   (A)	
   2-‐hour	
   control	
   mouse.	
   (D)	
   3-‐month	
  
rmTBI	
  microglia	
  exhibit	
  distinct	
  changes	
  to	
  morphology	
  with	
  large	
  cell	
  bodies	
  and	
  thick	
  cell	
  processes	
  
as	
  compared	
  to	
  age	
  matched	
  control	
  (C)	
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Figure	
  7.	
  Corpus	
  callosum	
  expression	
  of	
  activated	
  microglia.	
  More	
  activated	
  microglia	
  are	
  
apparent	
  in	
  the	
  (B)	
  2-‐hour	
  rmTBI	
  mouse	
  than	
  the	
  (A)	
  control	
  2-‐hour	
  mouse.	
  (D)	
  at	
  3-‐months	
  
post	
  rmTBI	
  microglia	
  remain	
  in	
  an	
  activated	
  morphology	
  compared	
  to	
  age	
  matched	
  control	
  (C).	
  	
  

Figure	
   8.	
   Cortex	
   expression	
   of	
   activated	
   microglia.	
   Activated	
   microglia	
   express	
   Iba1.	
   The	
  
dotted	
  box	
  in	
  (B)	
  surrounds	
  clustering	
  activated	
  microglia.	
  (D)	
  3-‐months	
  after	
  rmTBI	
  microglia	
  
remain	
   activated	
   in	
   the	
   cortex	
   with	
   large	
   cell	
   bodies	
   compared	
   to	
   those	
   seen	
   in	
   age	
   matched	
  
controls	
  (C).	
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Discussion
The objective of our rmTBI mouse study was initially to identify changes in
ventricular volume following repeated head injury. We hypothesize that alteration in
ventricular size or ependymal integrity could have negative implications for the SVZ stem
cell niche that lies along the lateral wall of the lateral ventricles. Stretching of the lateral
ventricles can lead to ependymal cell tearing, inducing glial scarring along the lateral wall
[28]. Glial scaring along this region may compromise the brains ability to remove toxic
molecules from the parenchyma into the CSF, exacerbating neurodegeneration and
possibly increasing neuroinflammation. The data from our ventricular tracing experiment
shows that following rmTBI lateral ventricular volume gradually increases over 3-months.
While we were unsurprised that there was expansion of the ventricles immediately
following rmTBI, as this is seen in human TBI patients, we did not expect the expansion to
continue throughout the entire 3-month period. This suggests that physicians caring for
rmTBI patients should play close attention to alterations in ventricular volume and size as
changes could have effects on global neuronal health and recovery. As the SVZ lies
directly along the lateral ventricles neurogenesis may also be impaired by glial scaring and
ventriculomegaly reducing the capacity for regeneration.
After observing a gradual increase in ventricular volume over 3-months in our
initial rmTBI mouse model study, we moved our focus towards the neuroinflammatory
process associated with rmTBI. We aimed to characterize microglial activation following
rmTBI using confocal microscopy. Our rmTBI mouse model, designed by Kane et al., was
specifically selected for its accurate replication of the rapid acceleration and deceleration
of the brain that commonly occurs in human rmTBI, such as in a sports concussion. These
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forces along with torsional rotation of the brain within the skull are thought to contribute to
the primary mechanical injuries of rmTBI including tearing and damage to axons, cell
bodies and neuronal networks. The leaking of intracellular molecules such as
neurotransmitters and reactive oxygen species into the extracellular space induces
secondary injury, leading to neuroinflammation and prolonged rmTBI symptoms. The
activation of microglia is known to play a central role in the neuroinflammatory pathway,
with M1 activated subtypes releasing pro-inflammatory cytokines and M2 microglia
counterbalancing by releasing anti-inflammatory molecules into the brain [7] and [8].
To gain a better understanding of the distribution of microglia throughout the brain
following rmTBI and the timeline of activation, we examined microglia in four different
brain regions: the lateral wall of the lateral ventricle, the hippocampus, the corpus callosum
and the cortex. We found that 2-hours after rmTBI noticeable changes in microglial
morphology could be observed in the lateral ventricle wall, the corpus callosum and cortex.
Cell processes were thicker and cell bodies increased in size. At 3-months following
rmTBI all experimental mice showed increased microglial activation over age-matched
controls. The hippocampus showed the greatest microglial activation compared to age
matched control. Observing microglia in an activated state 3-months following rmTBI
indicates the inflammatory process persists long after injury. If the activated microglia are
remaining in an M1 subtype, pro-inflammatory cytokines such as IL-1β that retard
recovery and promote rmTBI symptoms may still be modulating the brains environment
[7]. Recently, Fenn et al. showed mice with induced mTBI respond by releasing
significantly

more

pro-inflammatory

molecules

when

challenged

with

an

IP

lipopolysaccharide (LPS) injection, 30-days after mTBI injury, over control sham mice.
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Following the LPS injection, mTBI mice took much longer to return to their baseline
behavioral scores than control mice [7]. This study along with our own research indicates
that prolonged microglial activation can occur following rmTBI, and that the activated
microglia can prevent the brain from effectively responding to infection or injury for a
significant period of time following rmTBI. Further studies on the M1/M2 subtypes of
microglia present in the brain following rmTBI may be helpful in elucidating the
neuroinflammatory pathways and generating timelines for therapeutics.
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